---
$id: https://graph.org.ai/products/commodity/51111762
$type: Product
source: UNSPSC
code: "51111762"
title: "Romidepsin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Romidepsin

**UNSPSC Code**: 51111762
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antineoplastic antibiotic and depsipeptide with the molecular formula C24H36N4O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CX3T89XQBK, chemically known as l-valine, n-((3s,4e)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-d-valyl-d-cysteinyl-(2z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide but generally known as romidepsin, which bears US NIH Compound Identifier 5352062. European Medicines Agency schedules Romidepsin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26362. World Health Organization schedules romidepsin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule romidepsin under HS 29349990 and SITC 51579. As of Q4 2014, ROMIDEPSIN remains the US FDA Preferred Term for this commodity. Romidepsin bears US NLM identifiers UMLS ID C1527027 and NCI Concept Code C1544. SMILES: S1SCCC=CC2OC(=O)C(NC(=O)C(=C\C)\NC(=O)C(NC(=O)C(NC(=O)C2)C(C)C)C1)C(C)C.

